drugset / Trial / NCT04764396

Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies

NCT04764396

Terminated 2 enrolled University of Michigan
RandomizedParallel-groupDouble-blindBasic science

Summary

This is a randomized study that will enroll patients scheduled for an endoscopic ultrasound biopsy of a pancreas lesion to be in the heparin or saline group during the procedure. The purpose of this study is to examine the effect of blood contamination, heparin priming of the fine needle biopsies, and pass number on tumor tissue quality in fine needle biopsies. The hypothesis for this study is that fine needle biopsy tissue quality of pancreatic masses decreases with increasing pass number due to blood contamination; this blood contamination can be ameliorated with priming of the needle with an anticoagulant such as heparin.

Timeline

Start
2021-03-12
Primary completion
2021-04-06
Completion
2021-07-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 1 ml

Indications